Subclinical Elevation of Plasma C-Reactive Protein and Illusions/Hallucinations in Subjects with Parkinson’s Disease: Case–control Study - Sawada, Hideyuki; Oeda, Tomoko; Umemura, Atsushi; Tomita, Satoshi; Hayashi, Ryutaro; Kohsaka, Masayuki; Yamamoto, Kenji; Sudoh, Shinji; Sugiyama, Hiroshi (PloS one, 2014)
Keywords: Amantadine; Amantadine - therapeutic use; Antibiotics; Bioethics; Brain research; Bronchitis; C-reactive protein; C-Reactive Protein - metabolism; Case-Control Studies; Clinical trials; Cognitive ability; Confidence intervals; Consent; Cross-Sectional Studies; Cytokines; Delusions - psychology; Dementia; Diagnosis; Dihydroxyphenylalanine; Disease; Disease control; Disorientation; Dopamine; Dopamine Agents - therapeutic use; Hallucinations; Hallucinations - psychology; Health aspects; Hospitals; Humans; Illusions; Illusions - psychology; Infection; Infections; Inflammation; Levodopa; Levodopa - therapeutic use; Logistic Models; Medical research; Medicine; Mental disorders; Movement disorders; Multivariate Analysis; Neurodegenerative diseases; Neurology; Parkinson Disease - blood; Parkinson Disease - drug therapy; Parkinson Disease - psychology; Parkinson's disease; Patients; Plasma; Pneumonia; Proteins; Psychosis; Psychotic Disorders - psychology; Regression analysis; Regression models; Risk Factors; Selegiline; Selegiline - therapeutic use; Sleep; Sleep disorders; Social and Behavioral Sciences; Statistical analysis; Surveys and Questionnaires